RNF213 gene silencing upregulates transforming growth factor [beta]1 expression in bone marrow-derived mesenchymal stem cells and is involved in the onset of Moyamoya disease

• Published in: Experimental and therapeutic medicine Vol. 22; no. 3
• Main Authors: Wang, Changshui, Sun, Cuilian, Zhao, Yueshu, Song, Huimin, Li, Zhengyou, Jin, Feng, Cui, Changmeng
• Format: Journal Article
• Language: English
• Published: Spandidos Publications 01-09-2021
• Subjects: Development and progression; Gene expression; Gene silencing; Genetic aspects; Health aspects; Moyamoya disease; Stem cells; Transforming growth factors; Zinc finger proteins; China
• ISSN: 1792-0981
• DOI: 10.3892/etm.2021.10456

Moyamoya disease (MMD) is a chronic and progressive cerebrovascular occlusion disease, the precise etiology of which is poorly understood. Ring finger protein 213 (RNF213) has been previously identified as a susceptibility gene that serves an important role in angiogenesis, where it has been shown to be closely associated with the onset of MMD. Patients with MMD exhibit increased expression levels of various pro-inflammatory molecules and angiogenic factors. Under certain conditions, bone marrow mesenchymal stem cells (BMSCs) have the ability to differentiate to form neuron-like and microglia-like cells. In the present study, a total of 40 MMD patients and 40 healthy individuals were enrolled. ELISA assays revealed that the expression of serum vascular endothelial growth factor (VEGF) and transforming growth factor [beta]1 (TGF-[beta]1) were higher than that in healthy controls. Furthermore, rat BMSCs (rBMSCs) were isolated and cultured using the whole bone marrow adherence method, which were then phenotyped using flow cytometry. Osteogenic and adipogenic differentiation were determined by using Alizarin red and oil red O staining, respectively. RNF213 was knocked-down using a lentivirus-mediated short hairpin RNA system in passage three rBMSCs, and successful transfection of the RNF213 was confirmed by RT-qPCR and fluorescence imaging. The expression levels of VEGF and TGF-[beta]1 in these rBMSCs were measured on days 7 and 14, respectively. The results demonstrated that RNF213 knockdown upregulated TGF-[beta]1 at both protein and mRNA levels, but did not exert any effect on VEGF gene expression. In conclusion, these findings suggested that that RNF213 knockdown may contribute to aberrant TGF-[beta]1 expression via a pathway that remains to be unidentified, indicating that quantitative changes in RNF213 gene expression may serve an important role in the pathogenesis of MMD. Key words: Moyamoya disease, ring finger protein 213, bone marrow mesenchymal stem cells, vascular endothelial growth factor, transforming growth factor [beta]1